Wednesday, March 4, 2015

Athersys and Chugai Enter License Agreement and Collaboration to Develop MultiStem(R) Cell Therapy for Ischemic Stroke in Japan -

By applying the stem cell therapy several days after the stroke there is absolutely no way to determine if improvements are due to normal spontaneous recovery or the stem cells. This research will tell us nothing except safety.
http://globenewswire.com/news-release/2015/03/02/711155/10122426/en/Athersys-and-Chugai-Enter-License-Agreement-and-Collaboration-to-Develop-MultiStem-R-Cell-Therapy-for-Ischemic-Stroke-in-Japan.html

No comments:

Post a Comment